Assignee
ANGIOCHEM INC
CA·5 granted patents·19 pending applications·61 citations·filing 2005–2017
Top patents by PatentIndex Score
24 records- 0194US7557182B2Molecules for transporting a compound across the blood-brain barrierANGIOCHEM INC·Filed 2005·Granted Jul 7, 2009·37 cites·28 claims
- 0292US7902156B2Aprotinin polypeptides for transporting a compound across the blood-brain barrierANGIOCHEM INC·Filed 2005·Granted Mar 8, 2011·21 cites·14 claims
- 0370US9713646B2Potentiation of anticancer agentsANGIOCHEM INC·Filed 2015·Granted Jul 25, 2017·1 cites·19 claims
- 0468US10980892B2Methods for the treatment of leptomeningeal carcinomatosisANGIOCHEM INC·Filed 2016·Granted Apr 20, 2021·1 cites·19 claims
- 0565US9687561B2Peptide-dendrimer conjugates and uses thereofANGIOCHEM INC·Filed 2013·Granted Jun 27, 2017·1 cites·19 claims
- 0660US2015174266A1Aprotinin polypeptides for transporting a compound across the blood-brain barrierANGIOCHEM INC·Filed 2014·Application pending·0 cites
- 0758US2016106856A1Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxinANGIOCHEM INC·Filed 2013·Application pending·0 cites
- 0856US2015038429A1Etoposide and doxorubicin conjugates for drug deliveryANGIOCHEM INC·Filed 2014·Application pending·0 cites
- 0952US2018221497A1Potentiation of anticancer agentsANGIOCHEM INC·Filed 2017·Application pending·0 cites
- 1052US2017281787A1Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxinANGIOCHEM INC·Filed 2016·Application pending·0 cites
- 1149US2011039785A1Polypeptide-nucleic acid conjugates and uses thereofANGIOCHEM INC·Filed 2008·Application pending·0 cites
- 1249US2016375145A1Etoposide and doxorubicin conjugates for drug deliveryANGIOCHEM INC·Filed 2016·Application pending·0 cites
- 1347US2017080100A1Delivery of antibodies to the central nervous systemANGIOCHEM INC·Filed 2016·Application pending·0 cites
- 1446US2016367691A1Targeted enzyme compounds and uses thereofANGIOCHEM INC·Filed 2014·Application pending·0 cites
- 1545US2018015180A1Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereofANGIOCHEM INC·Filed 2017·Application pending·0 cites
- 1641US2016263236A1Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereofANGIOCHEM INC·Filed 2015·Application pending·0 cites
- 1741US2015290341A1Targeted iduronate-2-sulfatase compoundsANGIOCHEM INC·Filed 2013·Application pending·0 cites
- 1840US2016213760A1Aprotinin-derived polypeptide-antibody conjugatesANGIOCHEM INC·Filed 2013·Application pending·0 cites
- 1939US2015174267A1Compositions and methods for the transport of therapeutic agentsANGIOCHEM INC·Filed 2015·Application pending·0 cites
- 2037US2016263235A1Peptide therapeutic conjugates and uses thereofANGIOCHEM INC·Filed 2015·Application pending·0 cites
- 2136US2017326233A1Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxinANGIOCHEM INC·Filed 2015·Application pending·0 cites
- 2235US2014335163A1Targeted iduronate-2-sulfatase compoundsANGIOCHEM INC·Filed 2012·Application pending·0 cites
- 2335US2015147310A1Targeted enzyme compounds and uses thereofANGIOCHEM INC·Filed 2013·Application pending·0 cites
- 2435US2015037311A1Targeted lysosomal enzyme compoundsANGIOCHEM INC·Filed 2012·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →